Company / Cost of Revenue
Steris Cost of Revenue History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$3.1B
FY2024
5-year range
$2.3B / $3.1B
FY2020-FY2024
Trend
+4.7%
vs FY2023
Sector context
#23 of 107
Health Care
What the data says
Steris's cost of revenue of $3.1B is higher than 79% of companies in the Health Care sector (FY2024). Cost of Revenue has increased for 7 consecutive years, from $368M in FY2017 to $3.1B in FY2024.
Based on SEC 10-K filings.
$3.1B in FY2024 with a 5-year CAGR of +12.3%. Top quartile in the Health Care sector.
Increased from $2.6B to $3.1B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +9.3%
- 5-Year CAGR
- +12.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 107This company $3.1B Sector average $11.8B
▼
-74.1% below sector average
Key checks
Key Insights
- Steris's cost of revenue has grown for 7 consecutive years.
- 5-year CAGR of +12.3%, indicating consistent growth.
- In FY2024, cost of revenue increased 4.7% year-over-year.
- Ranks #23 out of 107 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $3.1B | +4.7% |
| FY2023 | $2.9B | +14.3% |
| FY2022 | $2.6B | +9.2% |
| FY2021 | $2.3B | +32.6% |
| FY2020 | $1.8B | +3.1% |
| FY2019 | $1.7B | +6.5% |
| FY2018 | $1.6B | +337.0% |
| FY2017 | $367.8M | -76.8% |
| FY2016 | $1.6B | - |
As of FY2024 · SEC 10-K · Updated Mar 13, 2026